Fri, Nov 28, 2014, 2:35 PM EST - U.S. Markets closed early today

Recent

% | $
Quotes you view appear here for quick access.

Alexza Pharmaceuticals Inc. Message Board

  • cabogordon cabogordon Jul 30, 2013 11:54 PM Flag

    SEC FILINGS

    Jul 30 05:34pm

    MJul 24 2013
    ALXA Alexza Pharmaceuticals Inc. King Thomas Braxton Pres, CEO 40,000 Purchase at $4.48 $179,351

    Jul 26 04:34pm

    MJul 24 2013
    ALXA Alexza Pharmaceuticals Inc. King Thomas Braxton Pres, CEO 40,000 Purchase at $4.48 $179,351

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Definetly positive.
      One question... what about latest directors options exercise back in May?
      I see price of derivatives are 0$...... but ex-prices are 4.68$........... so my understanding is that they paid for it.... not grants.
      Am I correct or not?
      tx in advance.

      • 1 Reply to longfcell
      • They pay when they sell. Example: Give/grant yourself some stocks at $2 as the CEO of ALXA Thomas King often does. No money changes hands. Stock goes to $4. You sell. You have to "pay" for the stock so essentially you get a check for $2 x #shares. These grants typically have expiration dates pretty far out in the future but if the stock is below the strike price then they simply expire and no money changes hands (except that King will grant himself some more options at a lower price in that case).

        You shouldn't be investing if you don't know this.

    • The second filing is just to correct wording in the first filing's notes. Check item #4.

      4. This Report is being filed solely to correct the foregoing footnotes to reflect the purchase vs. sale of shares reported therein.

 
ALXA
1.42-0.02(-1.39%)Nov 28 1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.